Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies.

Sathineni Ashwin Reddy Joseph NewmanOlivia C LeavyHakim GhaniJoanna Pepke-ZabaJohn E CannonKaren K ShearesDolores TaboadaKatherine BunclarkAllan LawrieCathie L SudlowColin BerryJames M WildJane A MitchellJennifer Kathleen QuintJennifer RossdaleLaura C Price Luke S G Howard Martin R WilkinsNaveed SattarPhilip ChowienczykAlfred Arthur Roger Thompson Louise V Wain Alex Robert HorsleyLing-Pei HoJames D ChalmersMichael MarksKrisnah PoinasamyBetty RamanVictoria C HarrisLinzy Houchen-WolloffChristopher E BrightlingRachael Andrea Evans Mark R Toshnernull null

Published in: The European respiratory journal (2024)

risk of developing CTEPH following COVID-19-related hospitalisation is low. Simple risk scoring is a potentially effective way of screening patients for further investigation.

Keyphrases

coronavirus disease
sars cov
pulmonary hypertension
end stage renal disease
chronic kidney disease
newly diagnosed
public health
quality improvement
pulmonary artery
respiratory syndrome coronavirus
drug induced
patient reported